GGrantIndex
← Leaderboards

Pablo Tamayo

Broad Institute, Inc.

$10,291,282
Attributed
$20,923,489
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY201125
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,923,489 · 6

By mechanism

U24$7,952,646 · 2
R01$6,211,941 · 2
U01$5,121,550 · 1
P01$1,637,352 · 1

Top collaborators

Most similar at Broad Institute, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Genomics

Research focus

GenomicsBaseCommunitiesData SetComputing MethodologiesAnticancer ResearchMalignant NeoplasmsGeneticPathway InteractionsResourcesResponseMutationData AnalysesResearch PersonnelSamplingCollectionTechnologyComputer SoftwareTrainingCatalogsMethodologyClustered Regularly Interspaced Short Palindromic RepeatsGenerationsCode

Grant awards (28)

Core 2: Bioinformatics/Biostatistics/Genomics$1,325,007
P01 · FY2025 · CA · contact PI
GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research$877,010
U24 · FY2024 · CA
Core 2: Bioinformatics/Biostatistics/Genomics$312,345
P01 · FY2024 · CA · contact PI
GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research$904,706
U24 · FY2023 · CA
GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research$904,706
U24 · FY2022 · CA
Supporting and evolving Gene Set Enrichment Analysis and the Molecular Signatures Database for cancer research$666,297
U24 · FY2022 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States$942,132
U01 · FY2021 · CA · contact PI
GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research$923,435
U24 · FY2021 · CA
Supporting and evolving Gene Set Enrichment Analysis and the Molecular Signatures Database for cancer research$679,895
U24 · FY2021 · CA
Next-generation Functional Genetic Screening of Un-screenable Traits$1,051,170
R01 · FY2020 · HG
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States$1,005,764
U01 · FY2020 · CA · contact PI
GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research$949,808
U24 · FY2020 · CA
Supporting and evolving Gene Set Enrichment Analysis and the Molecular Signatures Database for cancer research$679,895
U24 · FY2020 · CA
Next-generation Functional Genetic Screening of Un-screenable Traits$1,055,496
R01 · FY2019 · HG
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States$980,283
U01 · FY2019 · CA · contact PI
Supporting and evolving Gene Set Enrichment Analysis and the Molecular Signatures Database for cancer research$659,499
U24 · FY2019 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States$166,667
U01 · FY2019 · CA · contact PI
Next-generation Functional Genetic Screening of Un-screenable Traits$1,057,708
R01 · FY2018 · HG
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States$1,014,721
U01 · FY2018 · CA · contact PI
Supporting and evolving Gene Set Enrichment Analysis and the Molecular Signatures Database for cancer research$707,395
U24 · FY2018 · CA
Next-generation Functional Genetic Screening of Un-screenable Traits$1,057,708
R01 · FY2017 · HG
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States$1,011,983
U01 · FY2017 · CA · contact PI
Molecular Signatures to Characterize the Oncogenic State of Individual Tumors$226,449
R01 · FY2015 · CA · contact PI
Molecular Signatures to Characterize the Oncogenic State of Individual Tumors$148,409
R01 · FY2015 · CA · contact PI
Molecular Signatures to Characterize the Oncogenic State of Individual Tumors$411,038
R01 · FY2014 · CA · contact PI
Molecular Signatures to Characterize the Oncogenic State of Individual Tumors$356,463
R01 · FY2013 · CA · contact PI
Molecular Signatures to Characterize the Oncogenic State of Individual Tumors$423,750
R01 · FY2012 · CA · contact PI
Molecular Signatures to Characterize the Oncogenic State of Individual Tumors$423,750
R01 · FY2011 · CA · contact PI